A batch of Johnson & Johnson’s COVID-19 vaccine failed quality standards and can’t be used, the drug giant said Wednesday. A vaccine ingredient made by Emergent BioSolutions — one of about 10 companies that Johnson & Johnson is using to speed up manufacturing of its recently approved vaccine — did not meet quality standards, J&J said. As of Wednesday, J&J had provided about 6.8 million doses to the US vaccine effort, according to the Centers for Disease Control and Prevention’s online vaccine tracker. J&J said it was putting more of its manufacturing and quality experts inside Emergent’s factory to supervise production of the COVID-19 vaccine, a move meant to enable delivery of an additional 24 million vaccine doses through April. J&J said it still expects to deliver more than 1 billion vaccine doses globally by the end of the year.

Source: Egypt Independent April 01, 2021 08:14 UTC